Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ACADEMIA
ACADEMIA
- At Least 20% of Patients Taking Xeljanz against Guidelines: Interim Analysis of PMS
April 26, 2016
- AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
April 21, 2016
- 17 Japanese Medical Societies Jointly Recommend HPV Vaccines
April 20, 2016
- Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer
March 23, 2016
- It’s Time to Discuss Restart of HPV Vaccine Promotion, Panel Chief Says as Personal View
March 16, 2016
- Biomarkers Urgently Needed to Tackle Ballooning Immunotherapy Costs: Oncologist
March 15, 2016
- Japan’s First Diabetes Management Guidelines for Elderly to Be Announced in May
March 11, 2016
- Development of AT2 Receptor-Related New Drugs Forging Ahead Overseas, but Japan Is “Far Behind”
February 22, 2016
- Sanofi, Univ. of Tokyo Form Strategic Partnership on Drug Discovery Research
February 19, 2016
- Discussions on New Guidelines for Atherosclerosis Prevention Get Underway
February 9, 2016
- Japan Oncology Society Calls for Proper Use of Opdivo
January 22, 2016
- Experts Launch Japanese Society of Geriatric Pharmacy
January 7, 2016
- Shionogi Funding Research to Develop World’s First Drug for Preventing Postoperative Metastasis of Lung Cancer
January 5, 2016
- Over 200 Medical Institutions, 14 Drug Makers Participating in Project to Analyze Cancer-Related Genetic Disorders
December 14, 2015
- Viekirax Joins Fray in Hep C Market, Can It Crack into Harvoni’s Stronghold?
November 20, 2015
- Japan Geriatrics Society to Publish Guidelines for Safe Pharmacotherapy in the Elderly Next Month
November 18, 2015
- Japan Sepsis Management Guidelines to Be Revised Next Year
October 27, 2015
- Group Calls for Appropriate Dosing of Dementia Drugs
October 9, 2015
- Asia, Oceania Obesity Associations Adopt Declaration on “Obesity Disease”
October 6, 2015
- New Guidelines for Obesity Treatment to Set Thresholds to Evaluate Drugs
October 6, 2015
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…